Endometriosis patients benefit from high serum progesterone in hormone replacement therapy-frozen embryo transfer cycles: a cohort study
Observational
OA: hybrid
CC0
⤵ 9 in-corpus citations
AI-generated summary
Endometriosis patients undergoing HRT-FET cycles had higher live birth rates with serum progesterone levels of 118 nmol/l or above compared to lower levels.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
RESEARCH QUESTION: What is the optimal serum progesterone cut-off level in patients with endometriosis undergoing hormone replacement therapy frozen embryo transfer (HRT-FET) with intensive progesterone luteal phase support?
DESIGN: A cohort study, including 262 HRT-FET cycles in 179 patients all diagnosed with endometriosis either by laparoscopy or by ultrasound in patients with visible endometriomas. Pre-treatment consisted of 42 days of oral contraceptive pills and 5 days' wash-out, followed by 6 mg oral oestrogen daily. Exogenous progesterone supplementation with vaginal progesterone gel 90 mg/12h commenced when the endometrium was 7 mm or thicker. From the fourth day of vaginal progesterone supplementation, patients also received intramuscular progesterone 50 mg daily. Blastocyst transfer was scheduled for the sixth day of progesterone supplementation.
RESULTS: The overall positive HCG, live birth (LBR) and total pregnancy loss rates were 60%, 39% and 34%, respectively. The optimal progesterone cut-off level was 118 nmol/l (37.1 ng/ml) defined as the maximum of the Youden index. The unadjusted LBR was significantly higher in patients with progesterone measuring 118 nmol/l or above compared with patients with progesterone measuring less than 118 nmol/l (51% [44/86] versus 34% [59/176], P = 0.01), whereas the adjusted odds ratio for a live birth was 2.1 (95% CI 1.2 to 3.7) after adjusting for age, body mass index, blastocyst score, blastocyst age, quality and number of blastocysts transferred.
CONCLUSIONS: Serum progesterone levels above 118 nmol/l (37.1ng/ml) resulted in significantly higher LBR compared with lower serum progesterone levels, suggesting that a threshold for optimal serum progesterone exists.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (48)
- Analysis of serum and endometrial progesterone in determining endometrial receptivity via openalex
- Assisted reproductive technology for women with endometriosis, a clinically oriented review via openalex
- Bowel Endometriosis Syndrome: a new scoring system for pelvic organ dysfunction and quality of life via openalex
- Endometrial receptivity in eutopic endometrium in patients with endometriosis: it is not affected, and let me show you why via openalex
- Endometrial receptivity in the eutopic endometrium of women with endometriosis: it is affected, and let me show you why via openalex
- Estrogen receptor beta and matrix metalloproteinase 1 are coexpressed in uterine endometrium and endometriotic lesions of patients with endometriosis via openalex
- Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis via openalex
- History of endometriosis may adversely affect the outcome in menopausal recipients of sibling oocytes via openalex
- Homeostasis imbalance in the endometrium of women with implantation defects: the role of estrogen and progesterone via openalex
- Influence of endometriosis on assisted reproductive technology outcomes: a systematic review and meta-analysis via openalex
- Progesterone and Estrogen Signaling in the Endometrium: What Goes Wrong in Endometriosis? via openalex
- Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis via openalex
- Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- Role of estrogen receptor-β in endometriosis via openalex
- Use of oral contraceptives in women with endometriosis before assisted reproduction treatment improves outcomes via openalex
- W2605651913 via openalex
- W2762859009 via openalex
- W2894695736 via openalex
- W2899241696 via openalex
- W2906107223 via openalex
- W2908029558 via openalex
- W3004273286 via openalex
- W3008547364 via openalex
- W3132048214 via openalex
- W3135906313 via openalex
- W3157352057 via openalex
- W3190345669 via openalex
- W3199492746 via openalex
- W3211041473 via openalex
- W4206248186 via openalex
- W6673771426 via openalex
- W4242030375 via openalex
- W6757264759 via openalex
- W6799400504 via openalex
- W6803716800 via openalex
- W6806865447 via openalex
- W84583857 via openalex
- W858408936 via openalex
- W1112795483 via openalex
- W1512555213 via openalex
- W2124988811 via openalex
- W2129213273 via openalex
- W2131022957 via openalex
- W2150780222 via openalex
- W2153114583 via openalex
- W2159203244 via openalex
- W2169827333 via openalex
Cited by (10)
- Serum progesterone concentrations at frozen embryo transfer in women with adenomyosis and endometriosis: a retrospective cohort study 2026
- GnRH Agonist-Aromatase Inhibitor Pretreatment Before Frozen Embryo Transfer in Patients with Endometriosis, Adenomyosis or Both 2026
- Clinical challenges and therapeutic strategies in women with endometriosis, deep infiltrating endometriosis, and/or adenomyosis undergoing assisted reproductive technologies: a narrative review 2026
- Cumulative live birth rates under three consecutive IVF/ICSI treatment cycles are reduced in women with endometriosis and/or adenomyosis diagnosed by ultrasonography 2025
- Predictive Role of Progesterone Levels for IVF Outcome in Different Phases of Controlled Ovarian Stimulation for Patients With and Without Endometriosis: Expert View 2024
- Role of Progestins in Reproduction 2024
- Reply: Sticking to the facts instead of speculating: evidence against intensive luteal phase support in endometriosis patients undergoing HRT-FET cycles 2024
- The devil lies in the detail-the role of intensive exogenous progesterone supplementation in the endometriosis patient undergoing HRT-FET 2024
- Progesterone levels do not differ between patients with or without endometriosis/adenomyosis both in those who conceive after hormone replacement therapy-frozen embryo transfer cycles and those who do not 2024
- Reply of the authors: Endometrial receptivity in adenomyosis and/or endometriosis 2023
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:37:00.903258+00:00
License: CC0
· commercial use OK